Mangrove Partners Corbus Pharmaceuticals Holdings, Inc. Transaction History
Mangrove Partners
- $769 Million
- Q3 2024
A detailed history of Mangrove Partners transactions in Corbus Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Mangrove Partners holds 2,112,200 shares of CRBP stock, worth $35.1 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
2,112,200Holding current value
$35.1 Million% of portfolio
0.48%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CRBP
# of Institutions
4Shares Held
38.7KCall Options Held
0Put Options Held
0-
Kingsbury Capital Investment Advisors LLC Evanston, IL33.7KShares$559,7570.01% of portfolio
-
Exane Derivatives2.65KShares$44,0160.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.31KShares$38,4020.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Corbus Pharmaceuticals Holdings, Inc.
- Ticker CRBP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 125,268,000
- Market Cap $2.08B
- Description
- Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...